Islet Neogenesis in Diabetes

Islet neogenesis, the formation of new islets of Langerhans in the pancreas, is a potential avenue for therapeutic intervention in diabetes. The loss of insulin-producing beta cells contributes to hyperglycemia, especially in type 1 diabetes. Understanding the mechanisms that promote islet neogenesis is vital, as factors like growth factors and local microenvironments can influence this process. Recent research focuses on stem cell differentiation and regenerative medicine to stimulate the formation of new islets. Strategies enhancing islet regeneration may offer novel treatments for diabetes, aiming to restore insulin production and achieve better glycemic control in affected individuals.